Ocugen (OCGN) Cash from Investing Activities (2014 - 2026)
Ocugen posted quarterly Cash from Investing Activities of -$6000.0 for Q1 2026, up 94.12% year-on-year from -$3090.9 in Q1 2025, and up 82.86% on a QoQ basis from -$35000.0 in Q4 2025.
Ocugen (OCGN) has 13 years of Cash from Investing Activities data on file, last reported at -$6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 94.12% year-over-year to -$6000.0; the trailing twelve-month figure through Mar 2026 stood at -$215000.0 (up 81.06% YoY), and the FY2025 full-year result was -$311000.0, up 90.81% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$6000.0, up from -$35000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $5.7 million in Q2 2023 and bottomed at -$15.3 million in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$102000.0 (2025), against an average of -$1.0 million.
- The widest annual swing landed in 2022, when Cash from Investing Activities sank 7866.15%; it then surged 1643.05% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at -$15.3 million in 2022, then soared by 82.2% to -$2.7 million in 2023, then surged by 99.52% to -$13000.0 in 2024, then slumped by 169.23% to -$35000.0 in 2025, then soared by 82.86% to -$6000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$6000.0 (Q1 2026), -$35000.0 (Q4 2025), and -$86000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | -6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,000.00 |
| Mar 31, 2026 | -6,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Mar 31, 2025 | -102,000.00 |
| Mar 31, 2025 | -102,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | -507,000.00 |
| Sep 30, 2024 | -507,000.00 |
| Jun 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -513,000.00 |
| Mar 31, 2024 | -2.35 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | -15.30 Mn |
| Dec 31, 2022 | -15.30 Mn |
| Sep 30, 2022 | -83,000.00 |
| Sep 30, 2022 | -83,000.00 |
| Jun 30, 2022 | -1.37 Mn |
| Jun 30, 2022 | -1.37 Mn |
| Mar 31, 2022 | -223,000.00 |
| Mar 31, 2022 | -223,000.00 |
| Dec 31, 2021 | -192,000.00 |
| Dec 31, 2021 | -192,000.00 |
| Sep 30, 2021 | -350,000.00 |
| Sep 30, 2021 | -350,000.00 |
| Jun 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Mar 31, 2021 | -261,000.00 |
| Mar 31, 2021 | -261,000.00 |
| Dec 31, 2020 | -251,000.00 |
| Dec 31, 2020 | -251,000.00 |
| Sep 30, 2020 | -22,000.00 |
| Sep 30, 2020 | -22,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Mar 31, 2020 | -53,000.00 |
| Mar 31, 2020 | -53,000.00 |
| Dec 31, 2019 | -20,870.00 |
| Dec 31, 2019 | -20,870.00 |
| Sep 30, 2019 | -2.20 Mn |
| Sep 30, 2019 | -2.20 Mn |
| Jun 30, 2019 | -121,486.00 |
| Jun 30, 2019 | -121,486.00 |
| Mar 31, 2019 | -10,581.00 |
| Mar 31, 2019 | -10,581.00 |
| Sep 30, 2018 | 1.76 Mn |
| Sep 30, 2018 | 1.76 Mn |
| Jun 30, 2018 | -1.48 Mn |
| Jun 30, 2018 | -1.48 Mn |
| Mar 31, 2018 | -355,000.00 |
| Mar 31, 2018 | -355,000.00 |
| Dec 31, 2017 | 747,000.00 |
| Dec 31, 2017 | 747,000.00 |
| Sep 30, 2017 | 6.10 Mn |
| Sep 30, 2017 | 6.10 Mn |
| Jun 30, 2017 | -38,000.00 |
| Jun 30, 2017 | -38,000.00 |
| Mar 31, 2017 | -8.04 Mn |
| Mar 31, 2017 | -8.04 Mn |
| Dec 31, 2016 | -3,000.00 |
| Dec 31, 2016 | -3,000.00 |
| Sep 30, 2016 | -3,000.00 |
| Sep 30, 2016 | -3,000.00 |
| Jun 30, 2016 | -282,000.00 |
| Jun 30, 2016 | -282,000.00 |
| Mar 31, 2016 | -32,000.00 |
| Mar 31, 2016 | -32,000.00 |
| Dec 31, 2015 | -131,000.00 |
| Dec 31, 2015 | -131,000.00 |
| Sep 30, 2015 | -498,000.00 |
| Sep 30, 2015 | -498,000.00 |
| Jun 30, 2015 | -405,000.00 |
| Jun 30, 2015 | -405,000.00 |
| Mar 31, 2015 | -915,000.00 |
| Mar 31, 2015 | -915,000.00 |
| Dec 31, 2014 | -1.74 Mn |
| Dec 31, 2014 | -1.74 Mn |
| Sep 30, 2014 | -1.38 Mn |
| Sep 30, 2014 | -1.38 Mn |
| Jun 30, 2014 | -73,000.00 |
| Jun 30, 2014 | -73,000.00 |
| Mar 31, 2014 | -120,000.00 |
| Mar 31, 2014 | -120,000.00 |